Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9323)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 6, 2016 (publication date) through Dec 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lau MS, Tsai HH. Review of vedolizumab for the treatment of ulcerative colitis. World J Gastrointest Pharmacol Ther 2016; 7(1): 107-111 [PMID: 26855816 DOI: 10.4292/wjgpt.v7.i1.107] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v7/i1/107.htm |
| Number | Citing Articles |
| 1 |
Eoin P. Cummins, Daniel Crean. Hypoxia and inflammatory bowel disease. Microbes and Infection 2017; 19(3): 210 doi: 10.1016/j.micinf.2016.09.004
|
| 2 |
Lei Zhu, Lu-Ming Dai, Hong Shen, Pei-Qing Gu, Kai Zheng, Ya-Jun Liu, Lu Zhang, Jia-Fei Cheng. Qing Chang Hua Shi granule ameliorate inflammation in experimental rats and cell model of ulcerative colitis through MEK/ERK signaling pathway. Biomedicine & Pharmacotherapy 2019; 116: 108967 doi: 10.1016/j.biopha.2019.108967
|
| 3 |
Pedro Boal Carvalho, José Cotter. Mucosal Healing in Ulcerative Colitis: A Comprehensive Review. Drugs 2017; 77(2): 159 doi: 10.1007/s40265-016-0676-y
|
| 4 |
Jasmina El Hadad, Philipp Schreiner, Thomas Greuter. Update zur medikamentösen Therapie der Colitis ulcerosa. Schweizer Gastroenterologie 2023; 4(1): 19 doi: 10.1007/s43472-023-00092-8
|
| 5 |
Her Hsin Tsai. Dose escalation of vedolizumab in inflammatory bowel disease patients with secondary loss of response. GastroHep 2021; 3(2): 62 doi: 10.1002/ygh2.448
|
| 6 |
Amy Hsin-Chieh Hsieh, Mutaz Ferman, Michael P Brown, Jane M Andrews. Vedolizumab: a novel treatment for ipilimumab-induced colitis. BMJ Case Reports 2016; : bcr2016216641 doi: 10.1136/bcr-2016-216641
|
| 7 |
Azza Abdelfattah Ali, Ekram Nemr Abd Al Haleem, Sahar Abdel-Hafeez Khaleel, Amany Said Sallam. Protective effect of cardamonin against acetic acid-induced ulcerative colitis in rats. Pharmacological Reports 2017; 69(2): 268 doi: 10.1016/j.pharep.2016.11.002
|
| 8 |
Ali Abdullah Mohammed Alajlan, Ahmad Asri Awad Alanazi, Abdulrahman Ibrahim Abdullah Al Fahad, Abdullah Saleh Abdullah Almorshed, Abdullah Abdulrahman Mohammed Alrbian, Majed Ali Mohammed Alsawaji, Nawal Haif Bajad Al-Mutairi, Sanytan Ghazy Al Otaibi. The impact of biologics on the management of autoimmune diseases: A comprehensive review for pharmacists. International journal of health sciences 2018; 2(S1): 353 doi: 10.53730/ijhs.v2nS1.15289
|
| 9 |
Jianfang Zhang, Xiaomin Chen, Xinyi Mu, Mengwei Hu, Jiang Wang, Xiaojun Huang, Shaoping Nie. Protective effects of flavonoids isolated from Agrocybe aegirita on dextran sodium sulfate‐induced colitis. eFood 2021; 2(6): 288 doi: 10.53365/efood.k/147240
|
| 10 |
Alexandre Jentzer, Anne-Emmanuelle Depincé-Berger, Christian Genin, Xavier Roblin, Stéphane Paul. Nouveaux marqueurs diagnostiques et pronostiques des maladies chroniques inflammatoires intestinales. Revue Francophone des Laboratoires 2016; 2016(484): 49 doi: 10.1016/S1773-035X(16)30223-4
|
| 11 |
Congcong Li, Lu Wang, Juebo Zhao, Yucai Wei, Shuo Zhai, Min Tan, Kuikui Guan, Zhihong Huang, Chaoxi Chen. Lonicera rupicola Hook.f.et Thoms flavonoids ameliorated dysregulated inflammatory responses, intestinal barrier, and gut microbiome in ulcerative colitis via PI3K/AKT pathway. Phytomedicine 2022; 104: 154284 doi: 10.1016/j.phymed.2022.154284
|